Vicenta Gaspar-Yoo, MD Senior Vice President, Care Continuum and Transitions | Allegheny Health Network
Vicenta Gaspar-Yoo, MD Senior Vice President, Care Continuum and Transitions | Allegheny Health Network
Allegheny Health Network (AHN) has introduced a robotic exoskeleton, EksoNR, to assist patients with neurological injuries in regaining mobility. The device is manufactured by Ekso Bionics and is the first of its kind cleared by the FDA for stroke and spinal cord injury patients, as well as those with acquired brain injuries and multiple sclerosis.
Mary Maloney, a 13-year-old who suffered a spinal stroke following a trampoline accident in 2020, is among the patients benefiting from this technology. Her mother, Pam Surano, remarked on the exoskeleton's impact: "Witnessing the positive impact that the exoskeleton will have on her recovery and the lives of countless others is deeply moving."
Dr. Donald Whiting of AHN stated, "This technology represents a significant leap forward in our ability to provide advanced rehabilitation services for patients with neurological conditions." The exoskeleton allows early mobilization during recovery which can lead to improved outcomes.
Gary Hoover from AHN noted that while not all patients may walk independently with the device, it provides significant therapeutic benefits. He said it offers advantages such as weight-bearing activities essential for managing chronic neurologic injuries.
The acquisition of EksoNR was funded through donations exceeding $200,000 from organizations including West Penn Hospital Foundation and Miracles for Mary. This initiative aims to provide advanced care locally in Pittsburgh.
AHN's EksoNR is available at their Suburban facility in Bellevue for outpatient rehabilitation upon physician referral. More information can be found by contacting AHN directly.
Alerts Sign-up